Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease

Liver International

Volumn 26, Issue 10, 2006, Pages 1258-1267

  Kirsch, Richard ^a,b,c   Sijtsema, Helene P ^a   Tlali, Mpho ^a   Marais, Adrian D ^b   Hall, Pauline de la M ^a  

^a Department of Anatomical Pathology ^*  (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Fibrosis; Inflammation; Iron; Lipid peroxidation; Methionine choline deficient; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKADIENE; CHOLINE; CHOLINE BITARTRATE; HYDROXYPROLINE; IRON; LIPID; METHIONINE; TARTARIC ACID DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; FATTY LIVER; FEMALE; HISTOPATHOLOGY; INFLAMMATION; IRON OVERLOAD; LIPID PEROXIDATION; NONHUMAN; NUTRITIONAL ASSESSMENT; RAT; TISSUE DISTRIBUTION;

ALANINE TRANSAMINASE; ANIMALS; BODY WEIGHT; CHOLINE DEFICIENCY; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; HYDROXYPROLINE; IRON OVERLOAD; LIPID PEROXIDATION; LIVER; METHIONINE; ORGAN SIZE; RATS; RATS, INBRED F344;

EID: 33751020540     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01329.x     Document Type: Article

References (51)

1. Byron D, Minuk G Y. Clinical hepatology: Profile of an urban, hospital-based practice. Hepatology 1996; 24: 813-5.
2. Marchesini G, Brizi M, Morselli-Labate A M, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
3. Bacon B R, Farahvash M J, Janney C G, Neuschwan-der-tetri B A. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
4. Matteoni C A, Younossi Z M, Gramlich T, Boparai N, Liu Y C, Mccullough A J. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
5. Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
6. Sanyal A J. The pathogenesis of NASH: Human studies. In: Farrell G C, George J, Hall P de la M, McCullough A J, eds. Fatty Liver Disease: NASH and Related Disorders, 1st edn. Victoria: Blackwell Publishing, 2005; 76-90.
7. Bacon B R, Tavill A S, Brittenham G M, Park C H Recknagel R O. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983; 71: 429-39.
8. Bacon B R, Healey J F, Brittenham G M, et al. Hepatic microsomal function in rats with chronic dietary iron overload. Gastroenterology 1986; 90: 1844-53.
9. Park C H, Bacon B R, Brittenham G M, Tavill A S. Pathology of dietary carbonyl iron overload in rats. Lab Invest 1987; 57: 555-63.
10. Bonkovsky H L, Lambrecht R W, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 2003; 30: 137-44.
11. Tavill A S, Qadri A M. Alcohol and iron. Semin Liver Dis 2004; 24: 317-25.
12. Pietrangelo A, Gualdi R, Casalgrandi G, et al. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 1994; 19: 714-21.
13. Ramm G A, Li S C, Li L, et al. Chronic iron overload causes activation of rat lipocytes in vivo. Am J Physiol 1995; 268: G451-8.
14. George D K, Goldwurm S, Macdonald G A, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-8.
15. Chitturi S, Weltman M, Farrell G C, et al. HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002; 36: 142-9.
16. Bonkovsky H L, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421-9.
17. Bugianesi E, Manzini P, D'antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004; 39: 179-87.
18. Deguti M M, Sipahi A M, Gayotto L C, et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res 2003; 36: 739-45.
19. Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol 2005; 11: 393-5.
20. Angulo P, Keach J C, Batts K P, Lindor K D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
21. Mendler M H, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-63.
22. Younossi Z M, Gramlich T, Bacon B R, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30: 847-50.
23. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000; 355: 2181-2.
24. Fernandez-Real J M, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function. Diabetes 2002; 51: 1000-4.
25. Farrell G C. Animal models of steatohepatitis. In: Farrell G C, George J, Hall P de la M, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders, 1st edn. Victoria: Blackwell Publishing, 2005; 76-90.
26. Koteish A, Diehl A M. Animal models of steatosis. Semin Liver Dis 2001; 21: 89-104.
27. Teramoto K, Bowers J L, Khettry U, Palombo J D, Clouse M E. A rat fatty liver transplant model. Transplantation 1993; 55: 737-41.
28. Weltman M D, Farrell G C, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-53.
29. Plummer J L, Mackinnon M, Cmielewski P L, et al. Dose-related effects of dietary iron supplementation in producing hepatic iron overload in rats. J Gastroenterol Hepatol 1997; 12: 839-42.
30. Kirsch R, Clarkson V, Shephard E G, et al. Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies. J Gastroenterol Hepatol 2003; 18: 1272-82.
31. Hørder M, Rej R. Alanine transaminase. In: Bergmeyer H U, Bergmeyer J, Grassl M, eds. Methods in Enzymatic Analysis, 3rd edn. Weinheim: Verlag-Chemie, 1983; 444-56.
32. Mcgowan M W, Artiss J D, Strandbergh D R, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983; 29: 538-42.
33. Folch J, Lees M, Sloane S G H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
34. Bligh E G, Dyer W J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-7.
35. Vasankari T, Kujala U, Heinonen O, Kapanen J, Ahotupa M. Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin Chim Acta 1995; 234: 63-9.
36. Asakawa T. Thiobarbituric acid test for detecting lipid peroxides. Lipids 1979; 14: 401-6.
37. Asakawa T, Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 1980; 15: 137-40.
38. Markwell M A, Haas S M, Bieber L L, Tolbert N E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-10.
39. Reddy G K, Enwemeka C S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29: 225-9.
40. Beilby J P, Prins A W, Swanson N R. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue. Clin Chem 1999; 45: 573-4.
41. Tietz N W, Rinker A D, Morrison S R. When is a serum iron really a serum iron? The status of serum iron measurements. Clin Chem 1994; 40: 546-51.
42. Brunet S, Thibault L, Delvin E, Yotov W, Bendayan M, Levy E. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 1999; 29: 1809-17.
43. Hirosue T, Hosogai Y. Changes of hepatic lipid and fatty acid profiles in rats administered iron-deficient diet and ethanol. Food Chem Toxicol 1993; 31: 651-4.
44. Whittaker P, Chanderbhan R F. Effect of increasing iron supplementation on blood lipids in rats. Br J Nutr 2001; 86: 587-92.
45. Turbino-Ribeiro S M, Silva M E, Chianca D A Jr., et al. Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure. J Nutr 2003; 133: 15-20.
46. Kirk E A, Heinecke J W, Leboeuf R C. Iron overload diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 2001; 107: 1545-53.
47. Tsukamoto H, Horne W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96: 620-30.
48. Sochaski M A, Bartfay W J, Thorpe S R, et al. Lipid peroxidation and protein modification in a mouse model of chronic iron overload. Metabolism 2002; 51: 645-51.
49. Brown K E, Dennery P A, Ridnour L A, et al. Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats. Liver Int 2003; 23: 232-42.
50. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 200-8.
51. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001; 55: 333-9.